Lisa Juul Routhe, PhD

Lisa Juul Routhe, PhD

Lisa completed her doctorate at the Laboratory of Neurobiology Group at Aalborg University. She investigated neuroinflammation and iron handling in diseases with brain iron overload, such as haemorrhagic stroke and chronic neurodegenerative diseases.
Nicole Overmars

Nicole Overmars

Nicole is responsible for 2N Pharma’s external communication, including our social media presence. She has experience from previous roles in marketing and public relations.
Alex Leech

Alex Leech

Alex Leech was the founding CEO of Alchemab Therapeutics and raised a £60m ($82m) Series A in 2021. He is a serial biotech CEO having led Creabilis, a leading European dermatology company, until its acquisition by Sienna Biopharmaceuticals Inc. in December 2016 and...
John Kemp, PhD

John Kemp, PhD

John Kemp is currently the CSO of Syndesi Therapeutics. Former roles include Head of Neuroscience Discovery at Janssen, Belgium, and CEO of Evotec Neurosciences, which was spun-out from Evotec and raised a €25m Series A in 2004. Before joining Evotec, John was SVP and...